BÁO CÁO Y HỌC: "OVERVIEW OF THE DIAGNOSTIC VALUE OF BIOCHEMICAL MARKERS OF LIVER FIBROSIS (FIBROTEST, HCV FIBROSURE) AND NECROSIS (ACTITEST) IN PATIENTS WITH CHRONIC HEPATITIS C" DOC
Tìm thấy 10,000 tài liệu liên quan tới tiêu đề "BÁO CÁO Y HỌC: "OVERVIEW OF THE DIAGNOSTIC VALUE OF BIOCHEMICAL MARKERS OF LIVER FIBROSIS (FIBROTEST...":
12. Stuyver L, et al. Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 1995, 38: 137-57. 13. Zheng X, et al. Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotypi[r]
transplantation has made pre-transplant antiviral therapy a high priority for research. The low accelerating dosage regimen of Everson and colleagues has demonstrated good efficacy but must be replicated in other cohorts and centers. The development of new, non-immunomodulatory antiviral agents prom[r]
and severity of disease. Am J Gastroenterol 2001; 96:2957. 10. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35:367. 11. Marchesini G, Brizi M, Morselli-Labate AM, et al. A[r]
transplantation has made pre-transplant antiviral therapy a high priority for research. The low accelerating dosage regimen of Everson and colleagues has demonstrated good efficacy but must be replicated in other cohorts and centers. The development of new, non-immunomodulatory antiviral agents prom[r]
randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140(5):346-55. 27. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992;15(4):567-71. 28. Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients wi[r]
Murray-Lyon IM. Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993;40:330–333. 35. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J T[r]
recipients. Clinical Gastroenterol Hepatol. 2005; 10:S125-31 19. Lee W, Dieterich D. Challenges in the management of HIV and hepatitis C virus infection. Drugs. 2004;64(7):693-700 20. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with Human[r]
C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-29. 33. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in live[r]
18. Farci P, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med, 1996. 335(9): 631-4. 19. Vogt M, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Eng[r]
acute HCV infection persists and 4% to 20% of patients with chronic hepatitis C will develop liver cirrhosis within 20 years. In patients with liver cirrhosis, the risk to develop HCC is 1-5% per year. Current standard therapy is the combination of pegylated interferon-α (PEG-IFN-α) and ribav[r]
severe with occasional lymphoid aggregates (Figure 2) [4,11]. Actively proliferating bile ductiles are often seen. Risk factors for severe recurrent HCV include advanced donor age, HCV genotype 1, high HCV RNA levels before and after transplant, early histological recurrence of HCV, concomitant cyto[r]
2005;41:289-298. 24. Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and r[r]
6. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416–1421. 7. Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou[r]
the RM group (χ2=1.60, p=0.21). The genotypes of TNF-A T-1031C had no associations with the eradication rate. But among the RM group, the odd ratio (OR) of the TNF-A CT for the eradication rate relative to TT was marginally reduced (OR=0.05, 95% confidence interval, 0.002-1.19). Conclusions:[r]
glycemic control. Strength training is the most effective lifestyle intervention to increase muscle mass but limited data is available in older adults with diabetes. We determined the influence of strength training on muscle quality (strength per unit of muscle mass), skeletal muscle fiber hypertrop[r]
eliminated by enteric (25-35%) and renal (65-75%) ways. We define hyperuricemia the uric acid blood level over 8 mg/dl (4.76 µmol/l).[1] The impact of hyperuricemia is wide felt because it may cause pathologic consequences in several organs, such as kidney, brain, subcutaneous tissue, joints. Many s[r]
Muscle glycogen Muscle glycogen stores (a surrogate of glucose disposal) were determined by hexokinase enzymatic and spectrophotometric analyses (Sigma Diagnostics, St. Louis, MI) with a C.V. of 5% [21]. Muscle Strength One repetition maximum (1RM) was assessed twice on each machine at baseli[r]
from MedTex Company, Istanbul, Turkey. The chromatogram was developed with sodium phosphate and sodium azide buffers. Abnormal Hb was 20.0 % of the total Hb; HbA2; 2.0% and Hb A ;77.3% [6]. HbF value was determined by alkali denaturation method and found as 0.7 % [7]. The p50 values obtained (using[r]
. The PCR was con-ducted with initial denaturation at 95°C for 10 minutes, 30 cycles of denaturation at 95°C for 1 minute, an-nealing at 60°C for 1 minute, and extension at 72°C for 1 minute, and a final extension at 72°C for 5 minutes. The primers were F1: 5’-AGC[r]
isolated Japanese H. pylori strains (J-HM-CAP) ELISA (Kyowa Medex, Tokyo, Japan), were used for the identification of H. pylori-infected participants (in the control group the former was used and in the case group both were used.). An ELISA value of 2.3 or over was regarded as positive for both test[r]